SLN logo

SLN

Silence Therapeutics Plc

$6.31
-$0.04(-0.63%)
66
Overall
--
Value
66
Tech
--
Quality
Market Cap
$315.90M
Volume
181.36K
52W Range
$1.97 - $8.88
Target Price
$33.60

Latest News for SLN

Soluna Holdings Secures $100M Credit Facility
TipRanks Auto-Generated Newsdesk6 days agoNov 17, 2025

Soluna Holdings ( ($SLNH) ) has issued an announcement. Soluna Holdings reported a significant financial performance for the third quarter of 2025,......

Soleno Therapeutics Announces $100M Share Buyback Plan
TipRanks Auto-Generated Newsdesk11 days agoNov 12, 2025

Soleno Therapeutics ( ($SLNO) ) has issued an update. On November 11, 2025, Soleno Therapeutics announced that its Board of Directors approved an a......

Maxim Group Reaffirms Their Buy Rating on Stabilis Solutions (SLNG)
TipRanks Auto-Generated Intelligence Newsdesk15 days agoNov 08, 2025

Maxim Group analyst Tate Sullivan maintained a Buy rating on Stabilis Solutions yesterday. The company’s shares closed yesterday at $4.71. Sullivan......

Soluna Holdings Completes Phase 3 of Project Dorothy
TipRanks Auto-Generated Newsdesk17 days agoNov 06, 2025

The latest update is out from Soluna Holdings ( ($SLNH) ). On November 6, 2025, Soluna Holdings announced significant updates in their operations, ......

Cantor Fitzgerald Sticks to Their Buy Rating for Soleno Therapeutics (SLNO)
TipRanks Auto-Generated Intelligence Newsdesk18 days agoNov 05, 2025

Cantor Fitzgerald analyst Kristen Kluska maintained a Buy rating on Soleno Therapeutics yesterday and set a price target of $123.00. Kluska covers ......

H.C. Wainwright Keeps Their Buy Rating on Basilea Pharmaceutica (BSLN)
TipRanks Auto-Generated Intelligence Newsdesk19 days agoNov 04, 2025

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Basilea Pharmaceutica today and set a price target of CHF105.00. The company’s sha......

Basilea Achieves Sales Milestone with Cresemba in Europe
TipRanks Switzerland Auto-Generated Newsdesk19 days agoNov 04, 2025

Basilea Pharmaceutica ( ($CH:BSLN) ) just unveiled an announcement. Basilea Pharmaceutica announced a USD 30 million sales milestone payment trigge......

Silence Therapeutics Completes Enrollment for Phase 2 Study
TipRanks Auto-Generated Newsdeska month agoOct 23, 2025

Silence Therapeutics ( ($SLN) ) has provided an announcement. On October 23, 2025, Silence Therapeutics announced the completion of patient enrollm......

News data is sourced from MarketXLS API and updated regularly.
Showing 8 of 8 articles.

ABCD
1SymbolPriceChangeVol
2SLN$6.31-0.6%181.36K
3
4
5
6

Get Silence Therapeutics Plc Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.